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ABSTRACT
Fatty acids are compounds with limited water solubility that belong to the lipid class of
bio-organic compounds and can be utilized as a source of energy by the body or as precursors to
oxidized compounds that have roles in inflammation and in the regulation of vascular tone. The
prostaglandins are naturally occurring 20-carbon cyclopentano fatty acid derivatives produced in
mammalian tissue from polyunsaturated fatty acids (PUFAs) and are generated from
endoperoxide precursors of arachidonic acid and related polyunsaturated fatty acids by the
enzyme cyclo-oxygenase (COX). The lipoxygenase (LOX) enzymes convert arachidonic acid
into hydroperoxy derivatives of PUFAs termed leukotrienes, which play a role in asthma and
allergies. The reagent trimethyl silyl diazomethane (TMSD) which is less toxic and explosive
than other reagents such as diazomethane, has been developed for use in the methyl esterification
of drugs such as penicillin and some fatty acids. The objectives of the research were to (1)
optimize the TMSD reaction conditions, (2) determine whether the TMSD reaction could support
methylation of prostaglandins and other oxidized products of arachidonic acid, such as
prostaglandins PGE2 and PGF2α, (3) develop calibration curves for the fatty acids and
prostaglandins with appropriate internal standards for use with GC-MS, and (4) determine
whether this method could be used to characterize by GC-MS these lipids in cell culture and in
other cell-free systems, such as those containing enzymes like COX.
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INTRODUCTION
1.1 Polyunsaturated Fatty Acids (PUFAs)
Ingestion of polyunsaturated fatty acids (PUFA) will lead to their distribution to virtually
every cell in the body with effects on membrane composition and function, eicosanoid
biosynthesis, and signaling as well as in the regulation of gene expression (1). Dietary PUFAs
have effects on diverse physiological processes impacting normal health and chronic disease,
such as the regulation of plasma lipid levels, cardiovascular and immune function, insulin action,
and neuronal development and visual function (2-7). Cell-specific lipid metabolism and the
expression of fatty acid regulated transcription factors likely play important roles in determining
how cells respond to changes in PUFA composition.

1.2 Structural Characterization of PUFAs
Chemically, PUFA belong to the class of simple lipids and are categorized as such due to
the fact that they have two or more cis double bonds. The location of the first double bond,
counted from the methyl end of the fatty acid, is designated by the omega- or n- number. For
example, linoleic acid, in the n-6 family, is designated as C18:2 n-6 to indicate that it has 18
carbons and two double bonds, with the first double bond at the sixth carbon (Figure 1).
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Figure 1. Structural formula of saturated, monounsaturated, and polyunsaturated fatty acids

There are two main families of PUFA, the n-3 and the n-6 PUFA. These fatty acid families are
not interconvertible and have very different biochemical roles. Linoleic acid (n-6) (LA) and αlinolenic acid (n-3) (LNA), two of the main representative compounds, are considered to be
essential fatty acids (EFA); they must be provided in the diet because they cannot be synthesized
in the body and their absence from the diet has pathological consequences.

1.3 Sources of PUFA
Vegetable oils, such as canola oil, are the major sources of the n-3 fatty acid, LNA. In
particular, LNA is found in the chloroplast of green leafy vegetables, such as purslane and
spinach, and in flax seed, linseed, walnuts, and so on (8). Purslane (Portulaca olearacea), a
vegetable used in soups and salads along the Mediterranean basin and in Middle East, is the
richest source of LNA of any green leafy vegetable examined to date (Figure 2). Moreover, it is
one of the few plants known to be a source of eicosapentaenoic acid (C20:5 n-3, EPA) (8). Other
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sources of n-3 fatty acids include nuts and seeds, vegetables and some fruits, egg yolk, poultry,
and meat. Fish is the main source of EPA and of docosahexaenoic acid (C22:6 n-3, DHA, also
known as Cervonic acid) (9).

Figure 2. Canola flower, left, ( http://www.northerncanola.com/photo/index.asp);
Purslane flower, right
(http://www.4to40.com/earth/geography/htm/flowersindex.asp?counter=107)
(Simpoulos, A.P.[1986] Purslane: A terrestrial source of omega-3. N Engl J Med;
315[13], 833)
Vegetables are the main source of n-6 fatty acids. The most important n-6 fatty acid, LA, is
found in large amounts in western diets in corn oil, safflower oil, sunflower oil (Figure 3), and
soybean oil (10). It is plentiful in nature and found in practically all plant seeds, with the
exception of palm and cocoa.

Figure 3. Safflower plant (CARTHAMUS TINCTORIUS)
(from http://www.unigraz.at/~katzer/engl/Cart_tin.html)
14

1.4 METABOLISM OF PUFA
Plants can insert additional double bonds into oleic acid, a monounsaturated fatty acid
that has a double bond, to form LA (with two double bonds) and LNA (with three double bonds).
Vertebrate animals cannot insert double bonds more proximal to the methyl end than the seventh
carbon atom. Furthermore, all metabolic conversion occurs without altering the methyl end of
the molecule that contains the n-3 and n-6 double bonds. Therefore once ingested, n-3 and n-6
fatty acids are not interconvertible.
The diet primarily contains EFA in the form of LA and LNA, which are synthesized by
plants. Within the human organism these 18-carbon precursors can be elongated and desaturated
to produce more highly unsaturated members of their family, principally, arachidonic acid and
docosahexaenoic acid. The liver is the primary site for EFA metabolism, although it does take
place in other tissues as well (11).
The metabolic pathways of LN and LNA are depicted in Figure 4. The first part of this
pathway takes place in the endoplasmic reticulum and involves the formation of AA (20:4) and
docosapentaenoic acid (C22:5 n-3, DPA), which are produced by alternating elongation and
desaturation steps that are catalyzed by fatty acid elongase δ6- and δ5- desaturases. The
mechanism of the final conversion to 22:5 n-6 and DHA is not completely understood.
Traditionally this final step has been thought to occur via a δ4-desaturase (12), but no proof of
the existence of this enzyme has been ever found (13). Most lipid biochemists are convinced that
the last step occurs primarily via chain elongation and desaturation followed by a retroconversion step involving peroxismal beta-oxidation, via the “Sprecher pathway”(14).
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METABOLIC PATHWAY OF LINOLEIC ACID AND ALFA- LINOLENIC ACID
n-3 series

n-6 series
18:2
Linoleic acid

18:3
alfa-Linolenic acid
Δ6 desaturase

18:3

18:4

Elongase
20:3

Δ5 desaturase

20:4

20:4
Arachidonic acid

20:5
Eicosapentaenoic acid

Elongase
24:4

22:4

24:5

22:5

Δ4 desaturase

22:5

24:5

24:5
22:6
Docosahexaenoic acid

Docosapentaenoic acid

Figure 4. Metabolic pathways for formation of AA, DHA, and EPA from the precursors LN
and LNA .
For each fatty acid, two alternate pathways are shown, both of which are comprised of a
δ-6 desaturase and a retro-conversion step involving δ-4 desaturase.
(http://www.eunutroll.org/calvani.htm)

Infante and Huszangh (15,16) believe that the current evidence supports their proposal
that the biosynthesis of 22:5n-6 and DHA occur via separate channeled carnitine-dependent
mitochondrial pathways as shown in Figure 5. According to their view, the outer mitochondrial
membrane may well be the sole site for DHA, whereas EPA and AA could be synthesized in the
endoplasmic reticulum. They suggest that the mitochondrial and microsomal systems could be
interregulated, redundant systems. The essential features of this pathway include the transport of
acetate and long chain fatty acid substrates into mitochondria as carnitine esters (17), the use of
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D-α-tocopherol or its quinone metabolites as specific cofactors in this pathway (18), a much
greater incorporation of mitochondrial acetate when 22-carbon PUFA are present (19), and an
intra-mitochondrial source of acetyl units, such as acetyl-carnitine, as the acetyl donor.

n-3 δ 6 D
18:3n-3 -carnitine

elongation

E-18:3n-3

Carntine

E-18:4n-3
2-α -TQ

2-α –TQH2

E-20:4n-3
2-α -TQ

acetylcarnitine

carntine

E

n-3 δ 5 D
GPC
elongation

n-3 δ 4 D
22:6n-3PC
carntine

E-22:6n-3
acetyl
-carnitine

E22:5n-3

2-α –TQH2

2-α -TQ carntine

2-α –TQH2

E-20:5n-3
acetyl-carnitine

Figure 5. Enzymatic mechanism for the proposed mitochondrial carnitine- and αtocopherolquinone (α-TQ)-dependent channeled synthesis of DHA-containing
phospholipids with phsophatidylcholine (PC)(http://www.eunutroll.org/calvani.htm )

Several in vivo and in vitro studies on rats and other animals have shown that LNA is a
strong suppressor of n-6 fatty acid metabolism, whereas ten times as much LN is required to give
an equal suppression of n-3 metabolism (12). In vitro studies on rat liver microsomes has
confirmed that the n-6 and n-3 substrate competition occur at several steps in the microsomal
pathway (20). These effects may not only be mediated by direct competitive mechanisms, but
also very likely via regulation of the activity of desaturation and elongation enzymes at the level
of gene expression (21).

17

1.5 BIOLOGICAL AND FUNCTIONAL EFFECTS OF PUFA
Both LNA and LA are now regarded as nutritionally essential fatty acids (EFA).
However, all the classic symptoms of essential fatty acid deficiency (dermatitis, growth
retardation, and infertility) can be completely cured by administration of the n-6 fatty acids
alone. These symptoms relate to the biological function of n-6 fatty acids (22) examples of
which include LA, the structural component in the ceramides that provides a water barrier of the
skin and is involved in energy nutrition and fat absorption; AA, a precursor of the eicosanoids,
which are local hormones that participate in a number of physiological as well as
pathophysiological conditions (e.g. parturition initiation, platelet aggregation, renal electrolyte
regulation, blastocyte implantation, and activation of immune cells); and n-6 fatty acids, which
possibly also play a role as second messengers in signal transduction across cell membranes.
There is insufficient understanding of the essentiality of the n-3 fatty acids. The n-3 fatty
acids can partially substitute for the n-6 fatty acids, which may comprise a sparing effect to
ameliorate some of the EFA deficiency symptoms (e.g. growth retardation), but are now
considered also to have their distinct role.
The biological functions of dietary n-3 fatty acids in the organism involve a carbon
source for energy production and as a precursor to synthesis of other molecules (20). For
example, EPA and DHA serve as a precursor for “n-3 eicosanoids,” which have a much lower
potency than those that are derived from n-6 fatty acids and are only formed in considerable
amounts in tissues at fairly high dietary intakes of EPA and DHA. For this reason the effects of
n-3 fatty acids on the synthesis, bioactivity, and metabolic clearance of eicosanoid products
accounts partly for their anti-inflammatory properties. There is increasing evidence for a specific
role of DHA in membrane function, especially in retinal and other neuronal tissues. Deficiencies
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of n-3 PUFA lead to a loss of DHA from brain and retina rod outer segment phospholipids with a
compensatory replacement by 22:5 n-6 fatty acids. The minor change in membrane phospholipid
structure is sufficient to lead to memory loss, learning disabilities, and impaired visual acuity.

1.6 EICOSANOID METABOLISM
EFA in the plasma membrane serve as substrates for the enzyme cyclooxygenase (COX)
and lipoxygenase (LOX) and are converted into a number of important, very active, short-lived,
hormone-like compounds referred to as “eicosanoids.” The families of prostaglandins,
leukotrienes, and related compounds are called eicosanoids because they are derived from 20carbon EFA that contain three, four, or five double bonds (AA, EPA, and di-homo-γ-linolenic
acid or C20:3 n-6, DGLA) and include prostaglandins (PGE), prostacyclins (PGI), thromboxanes
(TXB) and leukotrienes (LTB).
In human beings, AA is the most abundant precursor; it is either derived from dietary LA
or ingested in the diet. Arachidonate is esterified in phospholipids of the cell membrane or other
complex lipids. The concentration of free AA in the cell is very low, so the biosynthesis of
eicosanoids depends primarily on its hydrolytic release from phospholipids in the cell membrane
by phospholipase A2 (PLA2). Eicosanoids influence numerous metabolic activities including
platelet aggregation, inflammation, hemorrhage, vasoconstriction, vasodilatation, blood pressure,
and immune functions. The overall synthesis of the prostaglandins, leukotrienes, and
thromaboxanes from AA and EPA are shown in Figure 6. AA is the substrate for the “series 2”
prostaglandins, the prostacyclins, the thromboxanes and the “series 4” leukotrienes, whereas
EPA is the substrate for the “series 3” prostanoids and the “series 5” leukotrienes. The PUFA-

19

mediated immune response may be altered by changes in the production of immunologic
mediators known as cytokines.
PROSTAGLANDINS
PGE2

PGE3

THROMBOXANE
PROSTACYCLIN

TXA2
PGI2

THROMOBOXANE
PROSTACYCLIN

PGH2

TXA2
PGI3

PGH3

ENDOPEROXIDES

COX-1

Growth factors
Cytokines, endotoxins

+

Tissue Phospholipids
COX-2
PLA2

EPA

AA
5-Lipoxygenase

Diet

5-HPEPE

5-HPETE
LTA-synthase
LEUKOTRIENES
LTA4

LTA5
LTC5

LTC4
LTD4

LTB4

LTB5

LTD5

Figure 6. PUFA Oxidation Metabolic Route: AA- and EPA-derived eicosanoids
(http://www.eunutroll.org/calvani.htm)
The synthesis of prostaglandins is accomplished by COX, a microsomal enzyme (also
known as endoperoxide synthase or fatty acid cyclooxygenase) that uses AA or EPA as a
substrate. There are two isoforms of this enzyme, COX-1 and COX-2. The former is
constitutively expressed in most cells (i.e. gastric mucosa, vasculature, glomeruli, and collecting
ducts of the kidney), and is concentrated in the endoplasmic reticulum. In contrast, COX-2 is
normally not present but may be induced, both in the endoplasmic reticulum and over the surface
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of the nucleus, by certain serum factors that serve as inflammatory cytokines (IL-11, IL-1beta,
IL-6, TNFα,), by growth factors (TGFβ, EGF), by tumor promoters, and by cAMP. Induction of
COX is inhibited by treatment with glucocorticoids such as dexamethasone (23, 15, 16).
Moreover, non-steroidal anti-inflammatory drugs compete directly with arachidonate for binding
to both COX-1 and COX-2 sites thus inhibiting their activity (16).
More recently, an “unorthodox” metabolic route for PUFA oxidation has been revealed.
In particular, PUFA derived from membrane phospholipids can undergo auto-oxidation in vivo,
generating a complex mixture of hydroperoxides, epoxides, and cyclic peroxides (24). Of
particular medical interest are the isoprostanes and epoxides of AA and other PUFA.
Isoprostanes of PUFA constitute a family of prostaglandin-related compounds that act as
autacoids. The urinary isoprostane index offers a method to estimate lipid peroxidation in
various diseases. Epoxides of PUFA can be formed by autooxidation, by cytochrome P450, and
possibly by the oxidative burst of inflammatory cells (24). Epoxides of LNA are toxic, whereas
epoxides of AA have a wide range of biological effects. The 5,6-epoxide of AA is an excellent
substrate for COX and thromboxane synthase and has vascular and renal effects (25,26).

1.7 ANALYSIS OF FATTY ACIDS AND PROSTAGLANDINS BY GAS
CHROMATOGRAPHY
The preparation of the methyl ester derivatives of fatty acids for analysis by gas
chromatography is by far the most common chemical reaction performed by lipid analysts. In
acid-catalyzed methylation or transesterification procedures, the most common and mildest
reagent is 5% (w/v) anhydrous hydrogen chloride in methanol. This method is best suited to bulk
preparation of the reagent. A simpler and safer procedure that is more suited to small-scale
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preparations involves the slow addition of a solution of acetyl chloride to cooled, dry methanol.
Some methyl acetate is formed as a by-product, but it does not generally interfere with
methylation. As an alternative to methanolic hydrogen chloride, a solution of concentrated
sulphuric acid in methanol transesterifies lipids in the same manner and at much the same rate. It
is very easy to prepare, although high temperatures are required for the reaction to occur and the
yield of methyl ester product is generally low.
In base-catalyzed methods, triglycerides and phospholipids are transesterified very
rapidly in anhydrous methanol in the presence of a basic catalyst, usually sodium methoxide,
which facilitates the exchange between glycerol and methanol, and the methyl esters required are
quickly obtained in quantitative yield. Free fatty acids are not esterified under such conditions,
so care must be taken to exclude water from the reaction medium to prevent the occurrence of
this unwanted and irreversible hydrolytic reaction. Sodium methoxide in anhydrous methanol,
prepared simply by dissolving fresh clean sodium in dry methanol, is the most popular reagent.
Boron trifluoride-methanol is very popular as a methylating reagent, but it has a number of
disadvantages. Inconsistent results are obtained with this method, which are thought to be due to
the age of the reagent, probably as a result of the formation of further fluoroboron compounds by
reaction with atmospheric oxygen. Apart from the undesirable reaction with unsaturated fatty
acids, boron trifluoride/methanol will also cleave the rings in cyclopropane fatty acids
(commonly encountered in microorganisms); and it reacts with the other reagents to produce
spurious peaks in chromatograms (27).
Pentafluorodiazoalkanes have been used to prepare derivatives from unesterified fatty
acids that are suitable for GC with sensitive electron-capture detection(28, 29, 30).Diazomethane
(31) reacts rapidly with unesterified fatty acids to give methyl esters but does not affect
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transesterification of other lipids. Solutions of diazomethane in diethyl ether (with a little
alcohol) are stable for short periods if stored in the dark over potassium hydroxide pellets at
refrigeration temperatures. However, if they are kept too long, polymeric by-products are
formed, which interfere with GC analyses (32-34). Diazomethane is potentially explosive and
great care must be exercised in its preparation; in particular, apparatus with ground-glass joints
and strong light must be avoided. The reagent is toxic and is liable to cause development of
specific sensitivity; nitrosamides used in the preparation of diazomethane must be handled with
care, as they are potential carcinogens. Small-scale procedures are recommended, because if
sensible precautions are taken, the risks to health are slight, while methyl esters are prepared
rapidly with virtually no formation of artifacts. Suitable micro-equipment is available from
commercial sources (34-36).
From the previous discussion, it is evident that there are a number of compounds with
highly similar structures, which play important roles and need to be measured in food materials
and in the body. High-performance liquid chromatography is a popular means by which
scientists resolve and quantify fatty acid and fatty acid-derived compounds, mainly because the
compounds that are measured do not have to be modified for analysis (37). However, in gas
chromatography, the molecules need to be made thermally stable to withstand vaporization for
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n
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Figure 7. Preparation of methyl ester of fatty acids
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entrance into the gas phase, usually to more apolar derivatives, that are volatile at GC-friendly
temperatures and thus require chemical modification (38). One moiety that is common to these
compounds is the carboxylic acid, which is commonly converted to the methyl ester prior to
analysis. Fatty acids are converted to the methyl esters (Figure 7) by a number of different
methods, including treatment with an acid catalyst (hydrochloric acid or sulfuric acid) in the
presence of methanol, tetramethyl ammonium hydroxide, borontrifluoride, IRA-400 and
methanolic hydrochloride, or diazomethane (27). Many of these reagents are unsuitable for
formation of methyl esters of prostaglandins due to conditions that may degrade these unstable
species, although diazomethane has enjoyed widespread use as an appropriate reagent for this
application (28). Unfortunately, there are a number of drawbacks to the use of diazomethane
that include a lengthy preparation of the reagent, a potential to explode, and precursors used for
preparation of diazomethane that are mutagenic and carcinogenic (35, 36, 34).
Trimethyl silyl diazomethane (TMSD) was originally used with methanol as the
methylating reagent in the preparation of drugs, organic compounds, and some fatty acids (39).
The mechanism for formation of the methyl ester with TMSD is shown in Figure 8. Three-point
GC calibration curves were demonstrated by Yokota et al.(40) to be linear over a three- to fourfold range, and the reagent was shown to be as capable as diazomethane in promoting the
formation of methyl esters as shown in Figure 9. Moreover, TMSD is stable, and so it does not
need to be prepared from a precursor compound, is less hazardous, and provides an excellent
yield at room temperature and thus does not require heat for efficient catalysis (40).
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Figure 8. Reaction mechanism for formation of fatty acid methyl esters with TMSD

GC chromatograms
Calibration Curves
Diazomethane

TMSD

(fatty acid/palmitic acid)

Peak Area Ratio

14:0
16:0

14:0
16:0

18:1

18:1
18:2

18:2

20:4

20:4

Figure 9. Calibration curves for fatty acid methyl esters (14:0, 16:0, 18:1, 18:2, and 20:4) and
comparison of GC chromatograms for fatty acid methyl esters prepared with TMSD
or diazomethane (from Ref. 40)
Several procedures have been described to recover lipids from organisms, mainly
bacteria, tissues, or cell types. The first study on the dissolution of lipid materials was done by
Chevreul (41). In 1879, Franz Von Soxhlet described the first method based on dissolution of
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milk lipids in diethyl ether (42). A further improvement was made in 1914 with a mixture of
ethanol:ether (3:1) for lipid extraction (43). Chloroform was used in extraction of lipids from
bacteria (44) or plant material (45). Folsch developed mild procedures for quantitative extraction
of brain lipids leading to the classical use of a chloroform-methanol mixture. The factors
affecting the extractability of lipids by solvents have been reviewed comprehensively by Zahler
and Niggli (46). Hexane is quite popular in the extraction of a wide range of lipid oxidation
products from biological media such as plasma, rat liver, and microsomes for quantitative
determination (47).
Adiposomes store ether lipids inside the cells for better packaging and distribution inside
the cell, particularly in the dynamic organelle system composed of neutral lipids surrounded by a
monolayer of phospholipids and associated proteins. Diethyl ether would seem to be an
appropriate solvent for extraction of these lipids since it has similar physical/chemical properties
to the molecules that require extraction (48). A mixture of hexane:diethyl ether was used in the
extraction of oxysterols and other lipid oxidation products from normal human arteries, fatty
streaks and other lipid oxidation products (49) . Whereas petroleum ether has been chosen as an
appropriate reagent for lipid extraction, hexane has been widely used in quantitative
determination of lipids and the lipid metabolites.
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1.8 OBJECTIVES OF THE RESEARCH PROJECT
The first objective of the research project is to study the TMSD reaction top determine [1] the
optimal amount of TMSD for methylation and [2] to attempt to develop the reaction for use in
safer solvents than the benzene solvent that is usually used. The second objective is to determine
whether the TMSD reaction could support methylation of C18 to C22 polyunsaturated fatty acids
and the prostaglandins, PGE2 and PGF2α. The third objective is to develop GC calibration curves
for these fatty acids and prostaglandins using appropriate internal standards. The final objective
involves an attempt to determine whether this method could be used as a part of the chemical
derivatization scheme to characterize these lipids by GC-MS in cell culture and other cell-free
systems, such as those containing enzymes like cyclooxygenase.

27

EXPERIMENTAL PROCEDURES
2.1 Fatty acid preparation
All of the fatty acids, arachidonic acid, linoleic acid, γ-linolenic acid, α-linolenic acid,
eicosapentanoic acid, docosahexanoic acid were shipped in an ethanol stock (Cayman Chemical,
Ann Arbor). A stock concentration of 1 mg/mL in ethanol was prepared for all of the fatty acids.
A sample calculation to determine the number of moles of arachidonic acid is shown below for
50 μL of the stock solution, which contained 1 mg/mL of arachidonic acid (MW = 304.5 g/mol).
1 mg/mL x 0.050 mL/304.5 g/mol = 1.642x10-7 mol.
In some experiments, the volume of fatty acid preparation used was kept constant, and therefore,
the concentration of the stock solution was varied to allow different concentrations of fatty acids
(preparation #1). In other experiments, stock concentrations of fatty acids were prepared in
ethanol as shown in Table 1 (preparation #2).

Table 1 Molecular weight and stock concentrations of fatty acids used for the experiments
Fatty acid

Molecular weight
(g/mol)

Stock conc. prepared
(mg/mL)

Arachidonic acid

318

2.5

Linoleic acid

294

2.3

Gamma- linolenic
acid
Alpha-linolenic acid

292

2.3

292

2.3

Eicosapentanoic
acid
Docosahexanoic
acid

302

2.5

342

2.6
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The internal standard used in the experiments was heptadecanoic acid. Heptadecanoic
acid (MW 270.45 g/mol) was provided as a powder, and a stock solution of 2.3 mg/mL ethanol
was prepared.

2.2 Preparation and optimization of the solvent system used in methyl esterification with
TMSD
We used the acetone-methanol solvent system (20% methanol in acetone), which
provided an optimal yield of methyl ester product relative to other solvent systems, with fewer
side products. For the preparation of 20% methanol in acetone, 800 μL of acetone is taken in the
test tube to which was added 200 μL of methanol, and the mixture was vortexed for 1 min prior
to use. The solvent system was prepared fresh daily (40).

2.3 Preparation and standardization of the methylating agent
A stock solution of 2.0 M TMSD was provided by Aldrich. The optimum concentration
used for all our reaction steps was 0.02 M TMSD. To make the stock solution, 10 μL of 2.0 M
TMSD was added to 990 μL of heptane, and the mixture was subjected to vortexing for 1 min.
Fresh TMSD reagent solutions were made on the day of their use (40).

2.4 Conversion of polyunsaturated fatty acids and phospholipids to their methyl esters by
TMSD
The procedure for methyl esterification of fatty acids by TMSD was modified from a
previously established procedure (40). A fixed quantity (10, 20, 50 μL) of each of the
polyunsaturated fatty acids and 10 μL of the internal standard, heptadecanoic acid, was added to
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a test tube, and the mixture was evaporated to dryness under a stream of nitrogen (N2). Addition
of 350 μL of 20% methanol-acetone solution was used to resuspend the fatty acid and provide a
source for the methyl group, after which an equal volume of 0.02 M TMSD was added, and the
mixture was vortexed for 1 min and left at room temperature for 20 to 30 min, vortexing
periodically (every 15 min). The mixture was evaporated under a stream of nitrogen or argon,
after which 100 μL of ethyl acetate was added to the lyophilized sample. The resulting products
were then subjected to analysis by gas chromatography-mass spectrometry.
An experiment was conducted in which varied amounts (50 μL to 500 μL) of TMSD
(with an equal volume of 20% methanol-acetone 1:1) were used with a constant amount of
arachidonic acid (20 μL of 1 mg/mL). The maximal production of arachidonic acid methyl ester
occurred at 100 μL of TMSD, and when a volume greater than 350 μL of TMSD was used, there
were additional, undesirable products formed. Fatty acids other than arachidonic acid required
amounts of TMSD up to 350 μL to give the methyl ester. The optimal amount required for the
reaction was eventually found to be 350 μL of 0.02 M TMSD (0.007 mol TMSD). For
convenience, we used equal volumes of the solvent system and the methylating agent. The
reactions were carried out at room temperature. The data for conversion of the fatty acids to their
methyl esters were confirmed by thin layer chromatography using silica as the stationary phase
and 0.1% glacial acetic acid as the mobile phase. TLC was also used to detect side products. The
products of the reaction in ethyl acetate were then subjected to gas chromatography and mass
spectrometry for analysis (50, 51).
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2.5 Methyl esterification of fatty acids contained in phospholipid and egg yolk
We also used the methylation process to identify the constituent fatty acids from
phosphatidylcholine containing palmitic acid and arachidonic acid. A 20 μL aliquot of the
sample from the stock concentration of 1 mg/ml (in water) was delivered to a test tube and
sonicated. Two mL of potassium hydroxide (10%) were added to the sample and heated at 50 οC
for one hour, after which 1M HCl was added to bring the pH to 3. Extraction of the liberated
fatty acids was accomplished with hexane in 10% (v:v) ether. The organic phase was collected
in a clean test tube, and the process was repeated two times. A pinch of magnesium sulfate was
added to the mixture, which was set aside for 1 hr to allow for the removal of water. The drying
agent was then removed by centrifugation. The extracted hexane layer was then evaporated
under nitrogen to bring it back to half of the original volume, which came to about 500 μL. The
saponified sample was preserved in argon. A certain fixed amount (10, 20, and 50 μL) of the
saponified sample was evaporated to dryness under N2, and the lyophilized sample was
resuspended in methanol/acetone solvent and subjected to methyl esterification by using TMSD
using the procedure outlined above.
A 20 μL sample of egg yolk (Eggland’s Best) and 2 mL of potassium hydroxide (10%)
were combined and heated at 50 οC for one hour, and fatty acid methyl esters were prepared in
the same manner as for those prepared from phospholipid. Fatty acid methyl esters were
prepared from fish oil capsules (Nature Made) in the same manner as those prepared from egg
white. The same procedure was followed for derivatisation of the fatty acid capsules as that for
the fortified egg yolk (52-54).
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2.6 Preparation of the stock solutions of prostaglandins
Dilute solutions of the prostaglandins PGE2 and PGF2α were prepared from a stock of
1mg/mL in ethanol. The stock solution was prepared by dilution in neat ethyl alcohol. Severalfold dilution of the prostaglandin was done to make a stock concentration of 1 ng/ml. The
deuterated sample of PGE2-d4 (Cayman Chemical) and PGF2α-d4 (Cayman Chemical) came as a
stock of 50 μg/ml in ethanol. The four deuterium atoms are located at the third and fourth
carbons at the carboxylate end of the prostaglandin. The deuterated-PGE2 and -PGF2α stocks
were diluted with 100% pure ethyl alcohol to a concentration of 1 ng/ml; 10 μL was used as an
internal standard in the calibration curve for the respective prostaglandin (55,56).

2.7 Methyl esterification of prostaglandins by TMSD
PGE2 derivatives for GC-MS analysis were prepared by first converting the carbonyl
group to an oxime according to a modification of the method of Kristrer Green (57), methylating
the carboxylic acid ester with TMSD, and then silylating the hydroxyl groups according to a
modification of the method used for penicillins and cephalosporins (58). A sample of PGE2 (1
ng/ml) was added to a test tube along with 10 μL of the deuterated sample (1 ng/ml), and solvent
was removed by evaporation under nitrogen. An aliquot (1 mg) of methyloxime in 100 μL of
pyridine was added to a test tube containing the lyophilized sample, vortexed for 1 min, and kept
in a hot water bath at 60 οC for 2 to 3 hr. The methyl ester was formed by using trimethylsilyl
diazomethane in a solvent system of 20% methanol in acetone using the same procedure as
described above. To prepare the silylated compound, the lyophilized derivative was resuspended
in 75 μL of bis-trimethylsilyl trifluoroacetamide (BSTFA) in 1% trimethyl chlorosilane (TMCS)
and 25 μL of pyridine, and the reaction was allowed to proceed in a hot water bath (60οC) for 1
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hr. The samples were then subjected to chromatography on a silica column and eluted from the
column with ethyl acetate, and the volume of the preparation was reduced to one-half of the
original volume prior to GC-MS analysis. PGF2α has only alcohol groups that require silylation,
and thus the methyl esterification was accomplished by the TMSD reaction, and then the three
hydroxyl groups were silylated as described for preparation of the PGE2 derivative.

2.8 Analysis of prostaglandins by methyl esterification in a cell-free system
To analyze prostaglandin production in cell culture, we have obtained cell culture media
in which A-549 cells and 9HTE cell-free system were grown. A 1.5-mL aliquot of the media
was mixed with 2 mL of distilled, deionized water that was acidified with HCl to pH 3.0, and the
mixture was kept on ice for 15 minutes. A prostaglandin-containing fraction was obtained by
purification on a C18 Sep-Pak cartridge column in the following manner. After application of
the sample, the column was washed with 15% methanol in acidified water (pH 3.0), followed by
2 mL of water and 2 ml of acetonitrile, and then washed with distilled, deionized water. The
prostaglandin fraction was eluted with 4 mL of methyl formate, which was evaporated under a
stream of nitrogen and then resuspended in solvent for derivatization according to the procedure
outlined for PGE2, except that a silica column was used after the methylation reaction (59-63).

2.9 Prostaglandin formation in the cylooxygenase-1 reaction
An amount of 100 μL of phosphate buffer was added to 50 μL of 1% Tween-20, 100 μL
of 50% glycerol, 100 μL of 2.5 mM phenol, and 8 μL of cylooxygenase-1 enzyme preparation
(0.8kU/μL sample; Cayman Chemical) to produce a total of 500 μL. An aliquot of 50 μL (from
2.5 mg/mL stock) of the fatty acid (arachidonic acid, γ-linolenic acid, or EPA) was added to a
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test tube and the solvent was removed under a stream of nitrogen. The 500 μL of the
components listed above were added to the tube containing the lyophilized fatty acid, and the
mixture was sonicated to resuspend the fatty acid. The whole reaction mixture was placed in a 37
o

C water bath for 25 min, after which 200 μL of anhydrous methanol and 100 μL of 1 M citric

acid were added to quench the reaction. Three successive extractions were done with hexane, and
the sample was prepared for GC-MS analysis per the procedure described for PGE2 (64-66).

2.10 Gas Chromatography and Mass Spectrometry Conditions
Methoxime and silyl derivatives of prostaglandin methyl esters were analyzed (62) in
chemical ionization mode and electron impact mode in GC-MS using the Saturn Varian 3800 GC
and 2000 MS with 8410 autosampler. Helium was used as the carrier gas with a VF-5 ms factor
four capillary column (30 m long, 0.25 mm i.d., 0.25 µM film thickness) (67). A 1 µL of the
sample was injected onto the column with a speed of 5 µL/sec. Chromatographic separations
were performed using a constant pressure injection of 10 psi. The GC column temperature, in
general, was programmed from 240 to 300 οC at a rate of 40 οC/min. In constant pressure mode,
the column flow rate would decrease as column temperature increased during the run. This
would cause a slight shift in the mass axis for the collection of the GC/MS data. To assure
correct mass assignments, the mass calibration was run with the GC column oven set at or near
the high temperature for the column program in the GC/MS method. For analysis of
prostaglandins in the chemical ionization and electron impact mode, in general, the injector
temperature was set at 250 οC with a column oven end-time of 18.50 min. The column flow was
maintained constant at 1.4 mL/min, with the stabilization time being 0.20 min. The detector
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bunch rate during data acquisition is 4 Hz as compared to the maximum value of 10Hz. The
noise monitor length is 64 sec, the bunched points being 6.4 sec.
The MS method was specified to have a 2.4 min solvent delay. As a rule, the first
chromatographic peak eluted shortly after 2.0 min. In all our experiments the elution time was
between 5 and 12 min, the full time length of running being 15 min. For CI method conditions,
the injector temperature was set at 250 οC and the column oven temperature was set at a range
between 200 to 300 οC, with a total holding time of 11 min. The initial signal noise ratio was
five with a deviation tolerance of 100% and a range tolerance of 10%. The CI reagent was
methanol.
In the EI method, the injector temperature was set at 250 οC. The column oven
temperature was set at a range of 200 to 275 οC with a total hold time of 12 min. The tolerance
range for the signal to noise detection was 20% as compared to CI mode, which was 10%. This
ensured a better signaling for the specific mass ions of the elutants.
Calibrating with an internal standard accounted for the variation in sample volumes lost
during sample preparation. A small amount of internal standard was added to sets of standards
and samples. Any variation in the sample volume was reflected by a detectable variation in the
ratio of the areas and amounts for the internal standard.
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Table 2: Gas Chromatography conditions for fatty acid methyl esters (chemical ionization mode)
Emission current

10 microamps

Mass defect

0mmu/100u

Count threshold

1 counts

Multiplier offset

0 volts

Scan time

10.00 secs

Segment start time

3.00 mins

Segment end time

10.00 mins

Segment low mass

40m/z

Segment high mass

650m/z

Ionization mode

CI

Table 3: Gas Chromatography conditions for Fatty Acid Methyl Esters (Electron Impact Mode)
Emission current

20 microamps

Mass defect

0 mmu/100u

Count threshold

1 counts

Multiplier offset

0 volts

Scan time

0.500 secs

Segment start time

3.00 mins

Segment end time

15.00 mins

Segment low mass

40m/z

Segment high mass

650m/z

Ionization mode

EI
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Table 4: Gas Chromatography Conditions for Prostaglandin Methyl Esters(Chemical Ionization
Mode)
Front injector type
1177
Temperature (oC)

250

Column flow (ml/min)

1.4

Table 5 : Column oven temperature for the Chemical Ionization Mode
Temperature (oC)

Rate (οC/min)

Hold (min)

Total (min)

200

-

2.00

2.00

240

40.0

0.00

3.00

304

8.0

0.00

11.00

Table 6: Gas-chromatography conditions for prostaglandin methyl esters( Electron Impact Mode)
Front Injector type

1177

Temperature (oC)

250

Column flow (ml/min)

1.2

Table 7 : Column oven temperature for the Electron Impact Mode
Temperature (oC)

Rate (οC/min)

Hold (min)

Total (min)

200

-

2.00

2.00

240

40.0

0.00

3.00

275

8.0

4.50

11.88
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RESULTS
3.1 Methylation of Fatty Acids/Optimization of the Methylation reaction for TMSD
In addition to defining the optimal amount of TMSD that was needed to form the methyl
ester, in experiments that were explained in the Experimental Procedure, there was also an
interest in evaluating several solvents for their ability to substitute for benzene as the solvent in a
reaction to form the methyl ester of arachidonic acid. Figures 10, 11, 12, and 13 show the
calibration curves for arachidonic acid methyl ester for benzene, ether, chloroform, and acetone,
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Figure 10. Calibration curve for methyl ester formation with TMSD using benzene as the
solvent. Each data point represents the average of two or more samples. The R2
value is 0.9988 and the equation for the line is y = 25.5x - 23.
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Figure 11. Calibration curve for methyl ester formation with TMSD using ether as the solvent.
Each data point represents the average of two or more samples. The R2 value is
0.9492 and the equation for the line is y = 58.16x – 54.25.

200

150

100

50

0
0

1

2

3

4

M ole Ratio,
Arachidonic Acid/Heptadecanoic Acid

Figure 12. Calibration curve for methyl ester formation with TMSD using chloroform as the
solvent. Each data point represents the average of two samples. The R2 value is
0.7764 and the equation for the line is y = 568x – 734.
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Figure 13. Calibration curve for methyl ester formation with TMSD using acetone as the
solvent. Each data point represents the average of two or more samples. The R2
value is 0.9385 and the equation for the line is y = 570700x – 1159000.
To aid in determining the optimal conditions for formation of the methylated fatty acids with
TMSD, the extent of the methylation reaction had to be monitored. The first and more
qualitative approach to determining the extent of the methylation involved thin layer
chromatography. The free and methylated fatty acids were separated on silica plates using a
solvent system containing an apolar solvent of hexane:diethyl ether:glacial acetic acid, with
phosphomolybdic acid as the reagent used to visualize the two species. Retention factor values
for the free and methyl esters of the fatty acids were 0.5 and 0.75, respectively, and TLC plates
showing native and methyl esters in preliminary studies for methylation with TMSD of a
linolenic acid is shown in Figure 14 (68, 69). There was originally a minimal conversion of
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linolenic acid to the methyl ester as shown by the relatively small amount of material with tR of
0.75 in Figure 14, but nearly complete conversion to the methyl ester was obtained following
optimization of the amount of TMSD used in the methylation (data not shown).

B

A

Figure 14. Thin layer chromatography of (A) free and (B) esterified after reaction of
linolenic acid with TMSD. The tR values of the free and esterified linolenic
acid are 0.5 and 0.75, respectively
The TLC was also used as the screening procedure to identify undesirable side
products. A more quantitative measurement to determine the percent conversion of the fatty acid
to its methyl ester was taken from the literature (70). The extent of conversion for a fatty acid in
the presence of the internal standard was determined by independently running the methylation
reaction for the fatty acid alone and then, in a second reaction, conducting the methylation
reaction with the fatty acid and the internal standard in the same reaction tube. The total number
of moles for the individual reactions was set equal to the total number of moles for the fatty acid
and internal standard together for the second reaction. The peak area of the fatty acid obtained
from the chromatographic data when assayed alone was divided by the peak area for the fatty
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acid in the reaction with the combined fatty acid and internal standard and multiplied by 100 to
obtain the percent conversion. The percent conversions for several fatty acids are given below in
Table 8, which reveals that all of the fatty acids tested were quantitatively converted to their
methyl esters except for linoleic acid. In addition to evaluation of solvents for the methylation
reaction supported by TMSD, other experiments were conducted to determine the optimal
amount of TMSD to use in the reaction (see Experimental Procedures).

Table 8: The extent of conversion of fatty acids in the TMSD reaction to the methyl ester
Fatty acid

Desgination

% Conversion

Linoleic acid
18:2
70
α-Linolenic acid
18:3
92
γ-Linolenic acid
18:3
90
Arachidonic acid
20:4
95
Eicosapentenoic acid
20:5
99
Docosahexenoic acid
22:6
100
___________________________________________________________________

3.2 Chromatograms and Mass Spectra of Some Fatty Acids Methyl Esters
The reaction with TMSD was carried out with a number of polyunsaturated fatty acids,
and the methyl esters were subjected to gas chromatography and ion trap mass spectrometry.
The chromatogram and mass spectra of the arachidonic acid methyl ester are shown in Figure 15.
Interestingly, the methyl ester elutes from the column in a non-Gaussian fashion, with a
considerable tail on the backside of the peak; the retention time for the apex of the peak occurs at
12.9 min, with most (about 90%) of the compound eluting from 12.8 to 13.2 min. The apex was
assayed for the mass spectrum, which possessed a prominent ion at 319 m/z, and other prominent
ions above 200 m/z of 203, 207, 221, 269, and 287. Three ions with an m/z of 97, 137 and 177
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m/z have been reported as prominent ions in the mass spectrum for arachidonic acid methyl ester
(71). These ions are envisioned to be generated by cleavage of the carbon-carbon bond on the
ester side of the double bonds that start at carbons 8, 11, and 14.
The chromatogram of the methyl ester of eicosapentanoic acid and its mass spectrum are
shown in Figure 16. The compound eluted from 13.0 to 13.5 min, its apex was at 13.1 min, and,
like arachidonic acid, was not Gaussian. One distinguishing ion had an m/z of 319, with other
ions above 200.

Figure 15. Chromatogram (above) and mass spectrum (below) of arachidonic acid methyl ester
generated by the TMSD methylation reaction.
The chromatogram of docosahexanoic acid methyl ester and its mass spectrum are shown
in Figure 17. The compound elutes in a range of 14.2 to 14.3 min and has a peak shape that is
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not Gaussian. The molecular ion is expected to have an m/z of 343, but it is not a prominent ion.
The other ions of m/z greater than 200 are those of 293, 310, and 213. Literature values for the
fragmentation products include m/z of 201, 274, and 299 (72). A similar pattern of ions below
m/z of 200 for all of the methyl esters generated thus far indicates that the regular structures of
all these polyunsaturated fatty acids are cleaved at similar carbon-carbon bonds in all these
molecules.

Figure 16. Chromatogram (above) and mass spectrum (below) of eicosapentanoic acid methyl
ester generated by the TMSD methylation reaction
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Figure 17. Chromatogram (above) and mass spectrum (below) of docosahexanoic acid methyl
ester.
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Figure 18. Chromatogram(above) and mass spectrum (below) were obtained for the methyl
ester of linoleic acid.
Chromatograms and mass spectra were obtained for the methyl esters of linoleic acid, αlinolenic acid, and γ-linolenic acid, which have prominent ions of 291, 294, and 293,
respectively, as shown in Figures 18, 19, and 20. These prominent ions presumably represent the
molecular ions.
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Figure 19. Chromatogram (above) and mass spectra (below) were obtained for the methyl esters
of α-linolenic acid.
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Figure 20. Chromatogram (above) and mass spectra (below) were obtained for the methyl
esters of γ-linolenic acid.
The oleic acid methyl ester was generated by the TMSD reaction, and its
chromatogram and mass spectrum are shown in Figure 21. Oleic acid methyl ester elutes as a
symmetrical peak, with an apex at about 12.2 min. The molecular ion at m/z 297 is the
prominent ion in the mass spectrum, with a secondary peak at m/z 263 (73).
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Figure 21. Chromatogram (above) and mass spectrum (below) for oleic acid methyl ester.
The compound that we wished to use as an internal standard, heptadecanoic acid, a 17carbon, saturated fatty acid, and heptadecanoic acid methyl ester chromatogram and mass
spectrum is shown in Figure 22 (74). Heptadecanoic acid methyl ester elutes from 11.8 to 11.9
min, with an apex at 11.85 min. The molecular ion with m/z of 285 is well represented in the
mass spectrum, and the other ion that is generated has an m/z of 251.
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Figure 22. Chromatogram (above) and mass spectrum (below) for heptadecanoic acid methyl
ester generated by the TMSD methylation reaction

3.3 Calibration Curves for Selected Polyunsaturated Fatty Acids
The calibration curves for arachidonic acid, eicosapentanoic acid, and docosahexanoic
acid methyl esters are shown in Figures 23, 24, and 25, with heptadecanoic acid used as the
internal standard. The standards were linear with concentration over four-, five-, and six-fold
range for AA, EPA, and DHA methyl esters, respectively. A range of values from one greater to
one less than the value for the molecular ion were used to calculate the peak area for each
compound and for the internal standard.
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Figure 23. Calibration curve for arachidonic acid methyl ester with heptadecanoic acid (HDA)
as the internal standard. The x-axis values represent the amount of arachidonic acid
in µL (concentration being 2.5 mg/mL).
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Figure 24. Calibration curve for eicosapentaenoic acid acid methyl ester with heptadecanoic
acid (HDA) as the internal standard. The x-axis values represent the mole ratio of
EPA to HDA, with a constant amount of HDA used for each standard.
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Figure 25. Calibration curve for docosahexanoic acid methyl ester with heptadecanoic acid
(HDA) as the internal standard. The x-axis values represent the mole ratio of
Docosahexaenoic acid to HDA, with a constant amount of HDA used for each
standard

3.4

Characterization of Chromatography and Mass Spectra of Prostaglandis PGE2 and
PGF2α
For TMSD to be truly useful as a broad-spectrum reagent for ester formation,

experiments were conducted to determine whether it could be used with prostaglandins, PGE2
and PGF2α, in a synthetic regime to produce derivatives that could be characterized by GC-MS.
The synthetic scheme for PGE2 involved, in successive reactions, the methoximation of the
carbonyl group, formation of the methyl ester with TMSD, and silylation of the hydroxyl group,
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as shown in Figure 26. The prostaglandins were subjected to gas chromatography that promoted
the elution of prostaglandins PGE2 and PGF2α at about 7.2 min. The chromatogram of the
derivative of PGE2 and its mass spectrum are shown in Figure 27. The peak shape was not
symmetrical, and assay of the mass spectrum of the compound at the apex revealed several
prominent ions, including a major ion with an m/z of 513.
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Figure 26. Synthetic scheme for production of the derivative of PGE2 that was subjected to gas
chromatography and mass spectral analysis.
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Figure 27. Chromatogram (above) and mass spectrum (below) of the PGE2 derivative. Several
chromatograms are overlaid, which show a variety of peak sizes related to different
amounts of PGE2.

The chromatogram and mass spectrum of derivative of deuterated PGE2 standard are
shown in Figure 28. The mass spectrum is rather complex with no prominent ions that will not
presently allow for the successful development of a quantitative assay for PGE2. Nevertheless, a
calibration curve for PGE2 was constructed for a series of PGE2 concentrations without the
internal standard and is shown in Figure 29. The curve was linear over a 90-fold range, with a
correlation coefficient of 0.9860. Work with the mass spec programming will need to be done in
an attempt to preserve the molecular ion to allow the successful distinguishing of the two PGE2
compounds within the same sample.
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Figure 28. Chromatogram (above) and mass spectrum (below) of PGE2-d4.
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Figure 29. Calibration curve for PGE2. Each data point represents the value for a single
determination and the total ion chromatogram was used to determine peak area. The
correlation coefficient is 0.9860 and the equation for the line is y = 9.9994x + 480

The derivatization of PGF2α required only the formation of the methyl ester and silyl
ethers as shown in Figure 30.
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Figure 30. Synthetic scheme for synthesis of a derivative of PGF2α.
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O CH3

The chromatogram of the PGF2α revealed an asymmetrical peak that, like the derivative for PGE2
and the mass spectrum generated by the derivative in the chemical ionization mode, is shown in
Figure 31.

Figure 31. The gas chromatogram (above) and the mass spectrum (below) of the standard
PGF2α.
The mass spectrum for PGF2α is virtually indistinguishable from that of the PGE2 derivative,
with the same prominent m/z 513 and 456 ions and identical minor ions of 150, 169, 249, 280,
and 500. Both derivatives PGE2 and PGF2α possess similar molecular weight occasionally with
different functional groups. The derivative for the deuterated form of PGF2α did not give a
substantial ion abundance in the chromatogram to be used successfully in a quantitative assay
(data not shown). A calibration curve was determined by assaying the peak area for various
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concentrations of PGF2α without the deuterated-PGF2α, and is shown in Figure 32. As with
PGF2α, the curve is linear over a 90-fold range with the lowest level evaluated 10 pg/mL.
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Figure 32. Calibration curve for PGF2α. Each data point represents the value for a single
determination, and the total ion chromatogram was used to determine peak area.
The correlation coefficient is 0.9828 and the equation for the line is y = 10220x +
112400.

3.5 Attempts to characterize fatty acids in phospholipids, egg yolk, and fish oil
Preliminary attempts were made to determine whether the methyl esterification of fatty
acids using the TMSD reagent could lead to their identification in biological samples. To
determine whether the fatty acids AA and palmitic acid can be identified, the phospholipids
phosphatidylcholine or phosphatidylethanolamine shown in Figure 33 were saponified to release
the fatty acids, and then the free fatty acids were esterified using the TMSD reagent (75, 76).
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Figure 33. Structures of phosphatidylcholine and phosphatidylethanolamine, which contain
palmitic acid (18:0) and arachidonic acid (20:4) at the SN1 and SN2 positions,
respectively.
The chromatogram of the resultant preparation shown in Figure 35 (panel A) contains only a
single peak centered at about 6.9 min, which is significantly less than the retention time for
arachidonic acid as shown in Figure 14. The GC conditions for this experiment were the same as
were used for the prostaglandins, which leads to an earlier elution for the fatty acids relative to
the conditions used for the fatty acids presented earlier in the Results. The mass spectrum of the
species at the apex of the peak is shown in Figure 36 (panel B). An m/z of 391 was observed in
a few experiments (not shown), which may be distinguishing for palmitic acid methyl ester (m/z
279), although palmitic acid methyl ester was not synthesized in this study.
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Figure 34. Chromatogram of the saponified and TMSD-treated hexane extract of
phosphatidylcholine and mass spectrum of the 6.85-min eluting species.

In another experiment, the fatty acids that were esterified in egg yolk were saponified in
potassium hydroxide, and the resultant fatty acids were then esterified with TMSD and resolved
and identified by GC-MS. The chromatogram of the broadly eluting peak and the mass spectrum
are shown in Figure 35. The mass spectrum at the peak of the chromatogram was complex and
does not have ions that distinguish any of the fatty acids.
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Figure 35. The chromatogram (above) and mass spectrum (below) of a sample of egg yolk that
was saponified and treated with TMSD to identify hexane-extracted fatty acids.
Finally, fish oil capsules were treated with potassium hydroxide to liberate the esterified
fatty acids, and the sample was treated with TMSD to make fatty acid methyl esters. The
chromatogram and the mass spectrum of the broadly eluting peak centered around 7.0 min are
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shown in Figure 36. The mass spectrum at the peak of the chromatogram was complex and does
not have ions that distinguish any of the fatty acids.

Figure 36. Chromatogram and mass spectrum of 6.9-min eluting species after saponification of
hexane-extractable fatty acids in fish oil
31and treatment with TMSD
3.6 Attempts to identify prostaglandins in media containing cultured cells
It is known that interleukin1β (IL1β) induces the secretion of PGE2 from a wellcharacterized alveolar cell line (A549), so the media in which this cell line was incubated was
used to determine the chemical synthesis scheme including the novel TMSD reagent could be
used to identify a PGE2 derivative in the media of cells treated for 0, 6, or 12 hours with IL1β. A
prostaglandin fraction was obtained following hexane extraction and purification on a silica
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column, after which the sample was treated with TMSD to form the methyl ester, the methyl
oxime, and BSTFA as per the PGE2 and PGF2α standards.

Figure 37. Chromatogram of media containing A549 cells purified on C18 column and treated
with reagents for preparation of the PGE2 derivative. Cells were treated with
interleukin1β for 0 (top), 6 (middle), or 12 hr (bottom).Mass spectrum of 6 hrs
treated A549 cells
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The chromatograms for all the time periods had a prominent peak in the region where
PGE2 and PGF2α standards elute are shown in Figure 39. Unfortunately, the mass spectrum
was complex and was not distinguishing for PGE2 or PGF2α.

Figure 38. Chromatogram of treated 9 HTE cells with IL-1β at an elution time of 7.00 mins for
0 hrs, 6 hrs and 12 hrs
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The chromatograms for the defined time periods had a prominent peak in the region where
the PGE2 and PGF2α standards elute are shown in Figure 41. Unfortunately, the mass spectrum
was complex and was not distinguishing for PGE2 or PGF2 α (data not shown).
3.7 Attempts to identify prostaglandins in reactions of cyclooxygenase-1 with arachidonic
acid
The metabolism of arachidonic acid by cyclooxygenase-1 is known to yield PGE2, which
is a decomposition product of PGH2, the product of the reaction with the enzyme. An attempt
was made to determine whether PGE2 could be identified in the reaction mixture after incubation
of arachidonic acid with the cyclooxygenase. The chromatogram for the reaction mixture that
was treated with TMSD to make the methyl ester, methyl oxime to modify the carbonyl group,
and the silylation of the alcohol groups is shown in Figure 40. A lipid specific fraction was
obtained by using a C18 column for purification. A single peak in the chromatogram that occurs
with the same retention time as for PGE2 is observed, and the mass spectrum of the species at the
peak of the chromatogram did match that of the purified PGE2 derivative standard as shown in
Figure 31. The ions with m/z of 513 and 456 that are distinguishing for PGE2 (and PGF2α for
that matter) are found in the mass spectrum.
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Figure 39. Chromatogram and mass spectrum of enzyme substrate reaction of
cyclooxygenase-.1 and arachidonic acid
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DISCUSSION

Diazomethane has been long considered as a common methylation agent for derivatisation of
mainly the carboxyl groups. However it has some major drawbacks, common among them are
concerned with its preparation which is time-consuming and complicated. The precursors used in
the preparation of Diazomethane are potent mutagens including diazomethane itself which is
carcinogenic and explosive. Hence Trimethyl Silyl Diazomethane was proposed as a potential
alternative to Diazomethane( Ref: Martina Preu).
Trimethyl silyl diazomethane (TMSD) was originally used with methanol as the
methylating reagent in the preparation of drugs, organic compounds, and some fatty acids (39).
TMSD is stable, and so it does not need to be prepared from a precursor compound, is less
hazardous, and provides an excellent yield at room temperature and thus does not require heat for
efficient catalysis (40).
The advantages of TMSD as the methylation agent as compared to all the previous
methods available is that it can be efficiently applied to analytical work by gas chromatography
and mass spectrometry.
Initial experiments were conducted to determine whether the benzene used as the cosolvent during methyl esterification of arachidonic acid with methanol could be substituted with
other solvents like chloroform, or acetone. The use of benzene-methanol as the solvent system
was developed as an alternative method to those involving chloroform-methanol (82). In
addition, the work presented here demonstrates that remarkably good results are obtained with
acetone-methanol as the solvent system (83). The acetone-methanol system was used to promote
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extraction of a lipid fraction, which was visualized by thin layer chromatography (84). Other
work demonstrated the use of 20% methanol-acetone as the solvent system in isolation of a lipid
fraction as revealed by thin layer chromatography (85). The widespread use of acetone-methanol
in solubilizing and derivatizing lipids was a main factor that influenced its use in the present
study. In the work presented here, a number of solvents were evaluated for use in the TMSD
reaction, and all of them provided marginal-to-acceptable linearity in support of the calibration
curve for arachidonic acid methyl ester. However, acetone has a relatively low toxicity and
provided superior linearity over a four-fold range.
The formation of the methyl ester of each of the polyunsaturated fatty acids tested yielded
a molecule with the expected molecular ions for arachidonic acid methyl ester (m/z 319),
eicosapentanoic acid methyl ester (m/z 319), docosahexanoic acid methyl ester (m/z 343), oleic
acid methyl ester (m/z 297), and heptadecanoic acid methyl ester (m/z 285), which was
subsequently used as the internal standard to develop the calibration curves for the
polyunsaturated fatty acids. The methyl ester for all of these compounds was confirmed by thin
layer chromatography, and confirmation by GC/MS analysis of the prepared fatty acid methyl
esters. The calibration curves for the PUFAs, AA, EPA, and DHA were linear over about a fourto five-fold range. These results extend the previously reported results to include PUFA of
greater molecular weights than fatty acids containing more than 20 carbon atoms. For fatty acids
with conjugated double bonds have attracted great interest because of their reported potent
bioactivity. It has been seen interestingly in our experiments that as the number of double
bonds increased the consumption of methylation agent increased accordingly. Hence the
optimum level of TMSD required for maximal conversion of linoleic acid with two double
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bonds was 60 μLs, for α and γ- linolenic acid with three double bonds is 70 μLs, for arachidonic
acid with four double bonds is 100 μLs, for eicosapentaenoic acid with – double bonds 150 μLs,
and docoahexaenoic acid with_ double bonds 300 μLs. Interestingly as predicted heptadecanoic
acid, which is a saturated fatty acid consumed 40 μLs of TMSD for full conversion.
The synthesis of the prostaglandins was a bit more complex and involved methoximation (PGE2)
and/or silylation of alcohol groups (PGE2 and PGF2α) and methyl esterification using the TMSD
reaction. The mass spectrum obtained following fragmentation under chemical ionization
conditions gave no evidence of the expected value for the molecular ion (m/z 538). The
calibration curve for PGE2 was linear over a 90-fold range, with the lowest concentration
evaluated at 10 pg/mL. Future experiments to find conditions to limit fragmentation will be used
to characterize the PGE2-derivative and the deuterated PGE2 standard, which did not provide a
substantial peak in the chromatogram. The calibration curve for the PGE2 and PGF2α
compounds showed linearity over a wide concentration range, although a better characterization
of the mass spectral properties of these compounds and those of the deuterated standards is
required to obtain a useful calibration curve for quantitation.
In the present study, several attempts were made to determine whether TMSD could be
used in an assay to detect fatty acids in biological samples. Saponification of the phospholipids,
phosphatidyl choline or phosphatidyl ethanolamine, and subsequent hexane extraction were
required prior to analysis of the palmitic acid and arachidonic acids that were contained in the
phospholipids. The hexane extractions that were subjected to treatment with the TMSD reagent
gave a single peak in the chromatogram. This single peak would suggest that palmitic acid is
present in the phospholipid as expected. Unfortunately, palmitic acid was not characterized and
so its presence in the phospholipid could not be confirmed. Moreover, the column conditions for
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detection of the fatty acid methyl esters were different from those earlier used for the standards,
and hence, the retention times could not be appropriately compared.
Experiments to identify PUFA in biological samples were performed with egg yolk and
fish oil capsules, which also first involved a saponification of the sample to release esterified
fatty acids prior to methyl esterification with TMSD in methanol-acetone. The chromatogram of
the sample was broad, and the mass spectrum at the apex of the peak revealed a complex
spectrum that did not allow characterization of the constituent fatty acids. Thus, much more
work needs to be done to more effectively identify these and/or other fatty acids in these
biological samples.
Attempts were also made to determine whether prostaglandins could be identified in
biological samples. The results obtained with a very well characterized alveolar cell line (A549)
did indicate that a peak in the chromatogram with a retention time of about 7.2 min was observed
in the media containing native or interleukin1β-treated cells. Interleukin 1β stimulates the
production of PGE2 in this cell line. Unfortunately, the chromatography is not good enough to
distinguish either of these prostaglandins in the cell culture media. On the other hand, the results
obtained with cyclooxygenase reaction with arachidonic acid gave the expected product, PGE2.
In summary, these experiments extend the number of polyunsaturated fatty acids that can
be evaluated in the TMSD-catalyzed reaction to those containing up to 22 carbon atoms, and also
to the class of eicosanoids known as the prostaglandins. The TMSD reaction is supported in
acetone, which is as effective as the considerably more toxic benzene solvent that was previously
used. Finally, the data suggest that it might be possible to identify fatty acids and prostaglandins
in biological reactions, although considerably more work will need to be done under the same
conditions for standards and for samples so that it is possible to make conclusions as to whether
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these compounds can be identified in biological samples. Finally, if chromatographic resolution
of the compounds cannot be achieved, selected ion monitoring or MS/MS methods may have to
be employed to identify and quantify the prostaglandins in biological samples. The application
of this procedure in biological systems detecting very minute amounts of prostaglandins
increases the applicability of this process in detecting prostaglandin like products, in biological
samples. This method can be extended for derivatizing thromboxanes and Leukotrienes. Hence
this method can be of importance in detecting fatty acids and their oxidation products in the field
of clinical chemistry.
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